Titre : Visiteurs des patients

Visiteurs des patients : Questions médicales fréquentes

Termes MeSH sélectionnés :

Neuromuscular Nondepolarizing Agents

Questions fréquentes et termes MeSH associés

Diagnostic 2

#1

Comment évaluer l'impact des visites sur le patient ?

L'impact peut être évalué par des questionnaires sur le bien-être et l'état émotionnel.
Évaluation Bien-être Visiteurs
#2

Quels signes indiquent qu'un patient a besoin de visites ?

Un patient peut montrer des signes de solitude, d'anxiété ou de dépression.
Solitude Anxiété Dépression

Symptômes 2

#1

Quels symptômes peuvent s'aggraver sans visites ?

L'isolement social peut aggraver l'anxiété et la dépression chez le patient.
Isolement social Anxiété Dépression
#2

Les visites peuvent-elles réduire la douleur perçue ?

Oui, le soutien émotionnel des visiteurs peut diminuer la perception de la douleur.
Douleur Soutien émotionnel Visiteurs

Prévention 2

#1

Comment prévenir l'isolement des patients ?

Encourager les visites régulières et utiliser des technologies de communication.
Isolement Visites Technologie
#2

Quelles mesures prendre pour des visites sûres ?

Respecter les protocoles d'hygiène et les restrictions de visite en place.
Hygiène Protocoles Visiteurs

Traitements 2

#1

Les visites font-elles partie du traitement ?

Oui, les visites peuvent être considérées comme un complément au traitement médical.
Traitement Soutien social Visiteurs
#2

Comment les hôpitaux gèrent-ils les visites ?

Les hôpitaux établissent des horaires et des règles pour assurer la sécurité des patients.
Gestion des visites Sécurité Hôpital

Complications 2

#1

Quelles complications peuvent survenir sans visites ?

L'absence de visites peut entraîner une détérioration de la santé mentale et physique.
Complications Santé mentale Santé physique
#2

Les visites peuvent-elles causer du stress au patient ?

Oui, des visites non planifiées ou trop fréquentes peuvent causer du stress.
Stress Visiteurs Planification

Facteurs de risque 2

#1

Quels facteurs augmentent le besoin de visites ?

L'âge avancé, les maladies chroniques et l'isolement social augmentent ce besoin.
Âge avancé Maladies chroniques Isolement social
#2

Les patients en soins intensifs ont-ils plus besoin de visites ?

Oui, les patients en soins intensifs peuvent bénéficier davantage du soutien des visiteurs.
Soins intensifs Soutien Visiteurs
{ "@context": "https://schema.org", "@graph": [ { "@type": "MedicalWebPage", "name": "Visiteurs des patients : Questions médicales les plus fréquentes", "headline": "Visiteurs des patients : Comprendre les symptômes, diagnostics et traitements", "description": "Guide complet et accessible sur les Visiteurs des patients : explications, diagnostics, traitements et prévention. Information médicale validée destinée aux patients.", "datePublished": "2024-03-31", "dateModified": "2025-03-26", "inLanguage": "fr", "medicalAudience": [ { "@type": "MedicalAudience", "name": "Grand public", "audienceType": "Patient", "healthCondition": { "@type": "MedicalCondition", "name": "Visiteurs des patients" }, "suggestedMinAge": 18, "suggestedGender": "unisex" }, { "@type": "MedicalAudience", "name": "Médecins", "audienceType": "Physician", "geographicArea": { "@type": "AdministrativeArea", "name": "France" } }, { "@type": "MedicalAudience", "name": "Chercheurs", "audienceType": "Researcher", "geographicArea": { "@type": "AdministrativeArea", "name": "International" } } ], "reviewedBy": { "@type": "Person", "name": "Dr Olivier Menir", "jobTitle": "Expert en Médecine", "description": "Expert en Médecine, Optimisation des Parcours de Soins et Révision Médicale", "url": "/static/pages/docteur-olivier-menir.html", "alumniOf": { "@type": "EducationalOrganization", "name": "Université Paris Descartes" } }, "isPartOf": { "@type": "MedicalWebPage", "name": "Personnes", "url": "https://questionsmedicales.fr/mesh/D009272", "about": { "@type": "MedicalCondition", "name": "Personnes", "code": { "@type": "MedicalCode", "code": "D009272", "codingSystem": "MeSH" }, "identifier": { "@type": "PropertyValue", "propertyID": "MeSH Tree", "value": "M01" } } }, "about": { "@type": "MedicalCondition", "name": "Visiteurs des patients", "alternateName": "Visitors to Patients", "code": { "@type": "MedicalCode", "code": "D014789", "codingSystem": "MeSH" } }, "author": [ { "@type": "Person", "name": "Samantha J Chiew", "url": "https://questionsmedicales.fr/author/Samantha%20J%20Chiew", "affiliation": { "@type": "Organization", "name": "Animal Welfare Science Centre, Faculty of Veterinary and Agricultural Sciences, The University of Melbourne, North Melbourne, VIC, Australia." } }, { "@type": "Person", "name": "Paul H Hemsworth", "url": "https://questionsmedicales.fr/author/Paul%20H%20Hemsworth", "affiliation": { "@type": "Organization", "name": "Animal Welfare Science Centre, Faculty of Veterinary and Agricultural Sciences, The University of Melbourne, North Melbourne, VIC, Australia." } }, { "@type": "Person", "name": "Sally L Sherwen", "url": "https://questionsmedicales.fr/author/Sally%20L%20Sherwen", "affiliation": { "@type": "Organization", "name": "Department of Wildlife Conservation and Science, Zoos Victoria, Parkville, VIC, Australia." } }, { "@type": "Person", "name": "Grahame J Coleman", "url": "https://questionsmedicales.fr/author/Grahame%20J%20Coleman", "affiliation": { "@type": "Organization", "name": "Animal Welfare Science Centre, Faculty of Veterinary and Agricultural Sciences, The University of Melbourne, North Melbourne, VIC, Australia." } }, { "@type": "Person", "name": "Vicky Melfi", "url": "https://questionsmedicales.fr/author/Vicky%20Melfi", "affiliation": { "@type": "Organization", "name": "Hartpury University and Hartpury College, Gloucester, United Kingdom." } } ], "citation": [ { "@type": "ScholarlyArticle", "name": "The Nonirritating Concentrations of Neuromuscular Blocking Agents and Related Compounds.", "datePublished": "2022-09-13", "url": "https://questionsmedicales.fr/article/36108924", "identifier": { "@type": "PropertyValue", "propertyID": "DOI", "value": "10.1016/j.jaip.2022.08.049" } }, { "@type": "ScholarlyArticle", "name": "Highly Water-Soluble Cucurbit[8]uril Derivative as a Broad-Spectrum Neuromuscular Block Reversal Agent.", "datePublished": "2022-12-08", "url": "https://questionsmedicales.fr/article/36480913", "identifier": { "@type": "PropertyValue", "propertyID": "DOI", "value": "10.1021/acs.jmedchem.2c01677" } }, { "@type": "ScholarlyArticle", "name": "Post-operative urinary retention is impacted by neuromuscular block reversal agent choice: A retrospective cohort study in US hospital setting.", "datePublished": "2023-11-25", "url": "https://questionsmedicales.fr/article/38007845", "identifier": { "@type": "PropertyValue", "propertyID": "DOI", "value": "10.1016/j.jclinane.2023.111344" } }, { "@type": "ScholarlyArticle", "name": "Findings of the neuromuscular blocking agent rocuronium in blood from deceased subjects several months after exposure: A report of two cases.", "datePublished": "2023-04-05", "url": "https://questionsmedicales.fr/article/37062138", "identifier": { "@type": "PropertyValue", "propertyID": "DOI", "value": "10.1016/j.forsciint.2023.111680" } }, { "@type": "ScholarlyArticle", "name": "Comparison of two electromyography-based neuromuscular monitors, AF-201P and TetraGraph, in rocuronium-induced neuromuscular block: A prospective comparative study.", "datePublished": "2022-08-31", "url": "https://questionsmedicales.fr/article/36057386", "identifier": { "@type": "PropertyValue", "propertyID": "DOI", "value": "10.1016/j.accpm.2022.101145" } } ], "breadcrumb": { "@type": "BreadcrumbList", "itemListElement": [ { "@type": "ListItem", "position": 1, "name": "questionsmedicales.fr", "item": "https://questionsmedicales.fr" }, { "@type": "ListItem", "position": 2, "name": "Personnes", "item": "https://questionsmedicales.fr/mesh/D009272" }, { "@type": "ListItem", "position": 3, "name": "Visiteurs des patients", "item": "https://questionsmedicales.fr/mesh/D014789" } ] } }, { "@type": "MedicalWebPage", "name": "Article complet : Visiteurs des patients - Questions et réponses", "headline": "Questions et réponses médicales fréquentes sur Visiteurs des patients", "description": "Une compilation de questions et réponses structurées, validées par des experts médicaux.", "datePublished": "2025-05-05", "inLanguage": "fr", "hasPart": [ { "@type": "MedicalWebPage", "name": "Diagnostic", "headline": "Diagnostic sur Visiteurs des patients", "description": "Comment évaluer l'impact des visites sur le patient ?\nQuels signes indiquent qu'un patient a besoin de visites ?", "url": "https://questionsmedicales.fr/mesh/D014789?mesh_terms=Neuromuscular+Nondepolarizing+Agents#section-diagnostic" }, { "@type": "MedicalWebPage", "name": "Symptômes", "headline": "Symptômes sur Visiteurs des patients", "description": "Quels symptômes peuvent s'aggraver sans visites ?\nLes visites peuvent-elles réduire la douleur perçue ?", "url": "https://questionsmedicales.fr/mesh/D014789?mesh_terms=Neuromuscular+Nondepolarizing+Agents#section-symptômes" }, { "@type": "MedicalWebPage", "name": "Prévention", "headline": "Prévention sur Visiteurs des patients", "description": "Comment prévenir l'isolement des patients ?\nQuelles mesures prendre pour des visites sûres ?", "url": "https://questionsmedicales.fr/mesh/D014789?mesh_terms=Neuromuscular+Nondepolarizing+Agents#section-prévention" }, { "@type": "MedicalWebPage", "name": "Traitements", "headline": "Traitements sur Visiteurs des patients", "description": "Les visites font-elles partie du traitement ?\nComment les hôpitaux gèrent-ils les visites ?", "url": "https://questionsmedicales.fr/mesh/D014789?mesh_terms=Neuromuscular+Nondepolarizing+Agents#section-traitements" }, { "@type": "MedicalWebPage", "name": "Complications", "headline": "Complications sur Visiteurs des patients", "description": "Quelles complications peuvent survenir sans visites ?\nLes visites peuvent-elles causer du stress au patient ?", "url": "https://questionsmedicales.fr/mesh/D014789?mesh_terms=Neuromuscular+Nondepolarizing+Agents#section-complications" }, { "@type": "MedicalWebPage", "name": "Facteurs de risque", "headline": "Facteurs de risque sur Visiteurs des patients", "description": "Quels facteurs augmentent le besoin de visites ?\nLes patients en soins intensifs ont-ils plus besoin de visites ?", "url": "https://questionsmedicales.fr/mesh/D014789?mesh_terms=Neuromuscular+Nondepolarizing+Agents#section-facteurs de risque" } ] }, { "@type": "FAQPage", "mainEntity": [ { "@type": "Question", "name": "Comment évaluer l'impact des visites sur le patient ?", "position": 1, "acceptedAnswer": { "@type": "Answer", "text": "L'impact peut être évalué par des questionnaires sur le bien-être et l'état émotionnel." } }, { "@type": "Question", "name": "Quels signes indiquent qu'un patient a besoin de visites ?", "position": 2, "acceptedAnswer": { "@type": "Answer", "text": "Un patient peut montrer des signes de solitude, d'anxiété ou de dépression." } }, { "@type": "Question", "name": "Quels symptômes peuvent s'aggraver sans visites ?", "position": 3, "acceptedAnswer": { "@type": "Answer", "text": "L'isolement social peut aggraver l'anxiété et la dépression chez le patient." } }, { "@type": "Question", "name": "Les visites peuvent-elles réduire la douleur perçue ?", "position": 4, "acceptedAnswer": { "@type": "Answer", "text": "Oui, le soutien émotionnel des visiteurs peut diminuer la perception de la douleur." } }, { "@type": "Question", "name": "Comment prévenir l'isolement des patients ?", "position": 5, "acceptedAnswer": { "@type": "Answer", "text": "Encourager les visites régulières et utiliser des technologies de communication." } }, { "@type": "Question", "name": "Quelles mesures prendre pour des visites sûres ?", "position": 6, "acceptedAnswer": { "@type": "Answer", "text": "Respecter les protocoles d'hygiène et les restrictions de visite en place." } }, { "@type": "Question", "name": "Les visites font-elles partie du traitement ?", "position": 7, "acceptedAnswer": { "@type": "Answer", "text": "Oui, les visites peuvent être considérées comme un complément au traitement médical." } }, { "@type": "Question", "name": "Comment les hôpitaux gèrent-ils les visites ?", "position": 8, "acceptedAnswer": { "@type": "Answer", "text": "Les hôpitaux établissent des horaires et des règles pour assurer la sécurité des patients." } }, { "@type": "Question", "name": "Quelles complications peuvent survenir sans visites ?", "position": 9, "acceptedAnswer": { "@type": "Answer", "text": "L'absence de visites peut entraîner une détérioration de la santé mentale et physique." } }, { "@type": "Question", "name": "Les visites peuvent-elles causer du stress au patient ?", "position": 10, "acceptedAnswer": { "@type": "Answer", "text": "Oui, des visites non planifiées ou trop fréquentes peuvent causer du stress." } }, { "@type": "Question", "name": "Quels facteurs augmentent le besoin de visites ?", "position": 11, "acceptedAnswer": { "@type": "Answer", "text": "L'âge avancé, les maladies chroniques et l'isolement social augmentent ce besoin." } }, { "@type": "Question", "name": "Les patients en soins intensifs ont-ils plus besoin de visites ?", "position": 12, "acceptedAnswer": { "@type": "Answer", "text": "Oui, les patients en soins intensifs peuvent bénéficier davantage du soutien des visiteurs." } } ] } ] }
Dr Olivier Menir

Contenu validé par Dr Olivier Menir

Expert en Médecine, Optimisation des Parcours de Soins et Révision Médicale


Validation scientifique effectuée le 26/03/2025

Contenu vérifié selon les dernières recommandations médicales

Auteurs principaux

Samantha J Chiew

3 publications dans cette catégorie

Affiliations :
  • Animal Welfare Science Centre, Faculty of Veterinary and Agricultural Sciences, The University of Melbourne, North Melbourne, VIC, Australia.
Publications dans "Visiteurs des patients" :

Paul H Hemsworth

3 publications dans cette catégorie

Affiliations :
  • Animal Welfare Science Centre, Faculty of Veterinary and Agricultural Sciences, The University of Melbourne, North Melbourne, VIC, Australia.
Publications dans "Visiteurs des patients" :

Sally L Sherwen

3 publications dans cette catégorie

Affiliations :
  • Department of Wildlife Conservation and Science, Zoos Victoria, Parkville, VIC, Australia.
Publications dans "Visiteurs des patients" :

Grahame J Coleman

3 publications dans cette catégorie

Affiliations :
  • Animal Welfare Science Centre, Faculty of Veterinary and Agricultural Sciences, The University of Melbourne, North Melbourne, VIC, Australia.
Publications dans "Visiteurs des patients" :

Vicky Melfi

2 publications dans cette catégorie

Affiliations :
  • Hartpury University and Hartpury College, Gloucester, United Kingdom.
Publications dans "Visiteurs des patients" :

Yongchao Hou

2 publications dans cette catégorie

Affiliations :
  • Emergency Department, ShanXi Provincial People's Hospital, Taiyuan, ShanXi, China.
  • School of Nursing, Midwifery & Health Systems, University College Dublin, Dublin, Ireland.

Melissa Corbally

2 publications dans cette catégorie

Affiliations :
  • School of Nursing and Midwifery, Trinity College Dublin, Dublin, Ireland.

Fiona Timmins

2 publications dans cette catégorie

Affiliations :
  • School of Nursing, Midwifery & Health Systems, University College Dublin, Dublin, Ireland.

Jocelyn A Srigley

2 publications dans cette catégorie

Affiliations :
  • Department of Pathology and Laboratory Medicine, BC Children's Hospital, Vancouver, BC, Canada; Department of Pathology and Laboratory Medicine, University of British Columbia, Vancouver, BC, Canada. Electronic address: jocelyn.srigley@cw.bc.ca.

Amy Damashek

2 publications dans cette catégorie

Affiliations :
  • Western Michigan University, Kalamazoo, USA.
Publications dans "Visiteurs des patients" :

Emily A Vargas

1 publication dans cette catégorie

Affiliations :
  • Department of Psychology, University of Michigan, Ann Arbor, MI, USA.
  • Department of Preventive Medicine, Feinberg School of Medicine, Northwestern University, Chicago, IL, USA.
Publications dans "Visiteurs des patients" :

Ramaswami Mahalingam

1 publication dans cette catégorie

Affiliations :
  • Department of Psychology, University of Michigan, Ann Arbor, MI, USA.
Publications dans "Visiteurs des patients" :

Riley A Marshall

1 publication dans cette catégorie

Affiliations :
  • Department of Psychology, University of Michigan, Ann Arbor, MI, USA.
Publications dans "Visiteurs des patients" :

Mark Otieno

1 publication dans cette catégorie

Affiliations :
  • Department of Animal Ecology and Tropical Biology, University of Würzburg, Würzburg, Germany.
  • Department of Agricultural Resource Management, University of Embu, Embu, Kenya.
Publications dans "Visiteurs des patients" :

Neelendra Joshi

1 publication dans cette catégorie

Affiliations :
  • Department of Entomology and Plant Pathology, University of Arkansas at Fayetteville, Fayetteville, AR, USA.
Publications dans "Visiteurs des patients" :

Benjamin Rutschmann

1 publication dans cette catégorie

Affiliations :
  • Department of Animal Ecology and Tropical Biology, University of Würzburg, Würzburg, Germany.
Publications dans "Visiteurs des patients" :

Audra N Iness

1 publication dans cette catégorie

Affiliations :
  • Division of Hematology, Oncology and Palliative Care, Massey Cancer Center, Virginia Commonwealth University, Richmond, Va; Department of Pediatrics, Baylor College of Medicine, Houston, Tex. Electronic address: audra.iness@bcm.edu.

Jefferson O Abaricia

1 publication dans cette catégorie

Affiliations :
  • Department of Bioengineering, College of Engineering, Virginia Commonwealth University, Richmond, Va.

Wendemi Sawadogo

1 publication dans cette catégorie

Affiliations :
  • Division of Epidemiology, Department of Family Medicine and Population Health, Virginia Commonwealth University, Richmond, Va.

Caleb M Iness

1 publication dans cette catégorie

Affiliations :
  • School of Medicine, California Northstate University, Elk Grove, Calif.

Sources (10000 au total)

The Nonirritating Concentrations of Neuromuscular Blocking Agents and Related Compounds.

Skin testing (ST) concentrations of neuromuscular blocking agents (NMBAs), NMBA-reversal agents, and the sugammadex-rocuronium inclusion complex (S-R-Cx) vary widely among reports.... To determine maximal ST nonirritant concentrations (NICs) of NMBAs (cisatracurium, rocuronium, succinylcholine, and vecuronium), NMBA-reversal agents (neostigmine and sugammadex), and S-R-Cx in NMBA-t... A single-center, prospective study between October 2019 and November 2021 of adult participants with or without a planned surgical procedure. The reference standard was tolerance of medication tested ... A total of 187 participants (78% NMBA-tolerant) underwent 7812 skin tests. All undiluted SPT concentrations were nonirritant. We found the following maximal IDT NICs (mg/mL): cisatracurium (0.02), roc... Our results suggest that SPT may be performed with undiluted stock concentrations. We confirm maximal IDT NICs for cisatracurium and rocuronium. We also propose that currently recommended maximal IDT ...

Post-operative urinary retention is impacted by neuromuscular block reversal agent choice: A retrospective cohort study in US hospital setting.

Perioperative neuromuscular blocking agents are pharmacologically reversed to minimize complications associated with residual neuromuscular block. Neuromuscular block reversal with anticholinesterases... Retrospective cohort study utilizing large healthcare database.... Non-profit, non-governmental and community and teaching hospitals and health systems from rural and urban areas.... 61,898 matched adult inpatients and 95,500 matched adult outpatients.... Neuromuscular block reversal with sugammadex or neostigmine plus glycopyrrolate.... Incidence of post-operative urinary retention by neuromuscular block reversal agent and the independent association of neuromuscular block reversal technique and risk of post-operative urinary retenti... The incidence of post-operative urinary retention was 2-fold greater among neostigmine with glycopyrrolate compared to sugammadex patients (5.0% vs 2.4% inpatients; 0.9% vs 0.4% outpatients; both p < ... Though this study suggests that neuromuscular block reversal with neostigmine can increase post-operative urinary retention risk, additional studies are needed to fully understand the association....

Findings of the neuromuscular blocking agent rocuronium in blood from deceased subjects several months after exposure: A report of two cases.

Rocuronium is a neuromuscular blocking agent mainly used in anesthetic procedures. Two patients who died 53 and 76 days, respectively, after their last rocuronium exposure had low (0.002-0.007 mg/L) l...

Comparison of two electromyography-based neuromuscular monitors, AF-201P and TetraGraph, in rocuronium-induced neuromuscular block: A prospective comparative study.

The study aimed to compare the responses obtained simultaneously from the newly developed electromyography (EMG)-based neuromuscular monitors, AF-201P and TetraGraph™, during rocuronium-induced neurom... Twenty patients were enrolled in this study. During total intravenous general anesthesia, train-of-four (TOF) responses following 0.9-mg/kg-rocuronium administration were monitored at the abductor dig... A total of 19 patients were analyzed. The supramaximal current was significantly lower with AF-201P than TetraGraph (31.7 ± 13.2 vs. 43.2 ± 8.2, p = .002). The time to first PTC (24.9 ± 9.4 vs. 27.3 ±... AF-201P showed faster recovery of rocuronium-induced neuromuscular block compared with TetraGraph....

Shortened time to neuromuscular recovery with lower doses of rocuronium in elderly patients.

The effect of neuromuscular blocking agents may be reversed by administration of neostigmine, when two twitches are present using train-of-four (TOF) stimulation. However, in elderly patients, limited... This was a secondary analysis of 50 elderly patients > 80 years; 16 patients received rocuronium 0.6 mg/kg, another 16 patients received rocuronium 0.9 mg/kg; and, finally, 18 patients received rocuro... Time to TOF-2 was shorter after rocuronium 0.6 mg/kg than after rocuronium 0.9 mg/kg: 37 min. versus 59 min. (difference: 22 min. (95% confidence intervals (CI): 10 to 33 min.), p = 0.0007). Time to T... Time to TOF-2 was shorter after rocuronium 0.6 mg/kg than after 0.9 mg/kg and shorter after rocuronium 0.3 mg/kg than after 0.6 mg/kg.... This work was supported by departmental sources.... This study was a secondary analysis of two clinical trials.... gov (NCT04512313), (NCT03857750)....

Use of neuromuscular blockade for neck dissection and association with iatrogenic nerve injury.

Cranial nerve injury is an uncommon but significant complication of neck dissection. We examined the association between the use of intraoperative neuromuscular blockade and iatrogenic cranial nerve i... This was a single-center, retrospective, electronic health record review. Study inclusion criteria stipulated patients > 18 years who had ≥ 2 neck lymphatic levels dissected for malignancy under gener... Our cohort consisted of 925 distinct neck dissections performed in 897 patients. Neuromuscular blockade was used during 285 (30.8%) neck dissections. Fourteen instances (1.5% of surgical cases) of ner... In this study, use of neuromuscular blockade intraoperatively during neck dissection was not associated with increased rates of iatrogenic cranial nerve injury. While this investigation provides early...